Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

MBX
MBX Biosciences Reports Q2 Results and Updates Pipeline

MBX Biosciences reported Q2 results highlighting progress on canvuparatide and MBX 4291 in the obesity pipeline with a robust cash balance....

INSIGHT
Insight Enterprises Q2 results led by AI demand

Insight Enterprises reported strong earnings growth driven by AI momentum. The company raised full-year guidance as cloud, infrastructure, and service...

NOVAVAX
Novavax reports Q2 revenue and updates 2026 guidance

Novavax reported $57M revenue and upwardly revised its 2026 revenue guidance driven by potential earnings from a Sanofi combination trial and existing...

Aurinia
Aurinia Q2 Beat with Revenue, Net Income Jump 21% and 60%

Aurinia Pharmaceuticals reported strong Q2 earnings with 21% revenue growth and a 60% increase in net income. The company also provided updated 2026 g...

Prime
Prime Medicine Reports Q2 2026 Results with WD IND Clearances and New AATD IND Target

Prime Medicine secured global regulatory clearance for its Wilson disease program. The company also reported a favorable arbitration outcome for its A...

Globalstar,
Globalstar Posts Record Q2 Revenue and Expiring Merger Wait Period

Globalstar reported $64.8 million in Q2 revenue driven by Commercial IoT growth. The company announced progress in its merger with Amazon, with the HS...

USA
USA Today reports Q2 results and reaffirms guidance

USA TODAY reported positive net income and free cash flow for Q2 2026 while reaffirming its full-year outlook. Total revenues declined 8.3% year-over-...

HERTZ
Hertz reports Q2 2026 results with record RPD and strong commercial momentum

Hertz reported Q2 2026 revenue of $2.4 billion, up 10% year-over-year, demonstrating strong commercial execution. The strong performance was attribute...

Parker-Hannifin
Parker-Hannifin reports record FY26 Q4, full year results

Parker-Hannifin posted record sales and adjusted earnings for FY26, beating expectations. The company raised its adjusted segment operating margin tar...

SUBURBAN
Suburban Propane Q3 Loss Widens Amid Warm Weather

Partner reported a $17.5M net loss for the third quarter of fiscal 2026, driven by warmer temperatures reducing demand, though volumes were supported ...

Viatris
Viatris Q2 2026 results: Up 5% revenue, $550M returned to shareholders

Viatris reported Q2 2026 Total Revenues of $3.8B and Adjusted EBITDA of $1.2B. The company raised full-year 2026 guidance and returned $550M to shareh...

AGENUS
Agenus advances Phase 3 ROBBIN trial of BOT+BAL in MSS colon cancer

Agenus reported Q2 2026 results and announced an accelerated Phase 3 trial for neoadjuvant colon cancer. The trial is fully funded via a July 2026 pri...

ABN
13F-HR - ABN AMRO Bank N.V. (0001561082) (Filer)

Institutional holdings report (13F-HR) filed by ABN AMRO Bank N.V.....

Cars.com
Cars.com Q2 2026 Results Miss Traffic Metrics, Exceed Profitability Goals

Cars.com reported Q2 2026 revenue of $179.9 million and a net increase of 103%, driven by sustainable profitability and 7% Marketplace revenue growth,...

Intellia
Intellia reports phase 3 HAELO trial success for lonvo-z

Intellia released positive Phase 3 data for its HAE treatment lonvo-z, received FDA guidance, and ended the quarter with strong liquidity....

Lantheus
Lantheus Reports Q2 2026 Financial Results

Lantheus reported Q2 2026 revenue of $388.2 million and EPS of $1.11, while announcing an all-cash agreement to merge with Curium for up to $8.0 billi...

Sabre
Sabre beats Q2/26 expectations, raises 2026 guidance

Sabre Corp reported Q2 2026 revenue surpassing expectations while raising full-year adjusted EBITDA and free cash flow guidance, demonstrating strong ...

Deep
Deep Isolation Reports Q2 2026 Financial Results

Deep Isolation reported $1.3 million in revenue with $3.0 million net loss, ahead of its first public trading experience where S-1 became effective an...

PepGen
PepGen reports Q2 2026 results, DSMB recommends dosing escalation.

Biotech company PepGen reported financial results affirming long-term solvency. It announced positive breakthroughs in its DM1 trial, including a Data...

ATI
ATI Q2 2026 Results Exceed Guidance, Raise Outlook

ATI Inc. reported Q2 2026 net income of $151 million, up 50% year-over-year, beating expectations. The company raised its adjusted EBITDA and EPS guid...